Most men would not have chosen a different treatment even if they had been aware of costs.
A clinic-based technique of targeted biopsy using MRI and ultrasound may improve the diagnosis and management of prostate cancer.
Use of the oral antidiabetes drug metformin improved survival in women with ovarian cancer, according to the findings of a retrospective case-control study.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
An intrauterine device releasing the progestin levonorgestrel was effective therapy for early endometrial cancer in women not fit for surgery.
An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.
Robotic-assisted laparoscopic radical prostatectomy exceeded the cost of open radical retropubic prostatectomy by almost $5,300 per case.
Six years after breast cancer treatment, more than 60% of women experienced at least one side effect amenable to rehabilitative intervention.
Robotic-assisted laparoscopic radical cystectomy (RARC) results in fewer problems and deaths than open cystectomy, but lengths of stay are similar and RARC costs more.
Advanced profiling of gene mutations in acute myeloid leukemia could potentially be used to help predict prognosis and guide treatment decisions.
Nearly 25% of women undergo reexcision after partial mastectomy, with substantial surgeon and facility variation seen in rates of reexcision.
Cancer patients with diabetes who took metformin were found to have a significantly lower overall mortality than cancer patients without diabetes.
Physical activity was associated with important positive effects on physical functions and quality of life in persons who had completed their treatment for cancer.
Providing men with noise-canceling headphones that play music may be a simple intervention for reducing their anxiety and pain perception while they are undergoing a prostate biopsy.
A meta-analysis provides reassurance that androgen deprivation therapy is not associated with an increased risk of cardiovascular deaths, but other specialists warn against ignoring this risk.
Offering CT colonography improved participation in colorectal cancer screening by more than 50% compared with colonoscopy, but colonoscopy identified significantly more advanced neoplasia.
Erlotinib is a marginally cost-effective treatment for patients with advanced non-small cell lung cancer, according to the results of an economic analysis published in the Journal of the National Cancer Institute (2010;102(5):298-306).
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|